MedMen
Presence
MedMen is a company listed under the stock ticker MMEN (US).
Acquisition, funding and merger involving MedMen.
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
Executives
View the org chart displaying its 12 main executives
Most searched biographies at MedMen
Popular executive movements at MedMen
- Amit Pandey, Chief Financial Officer, has left the company (posted on April 28 2024).
- Richard Ormond, Chief Restructuring Officer, has left the company (posted on April 28 2024).
- Michael Serruya, Chairman of the Board, has left the company (posted on January 26 2024).
Click here to view some more movements at MedMen
Create your alert
to follow the executive moves at MedMen.
Pharmaceuticals
MedMen has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by MedMen
- MedMen Launches Delivery Services Across California
- MedMen Cannabis Dispensaries and Delivery Service
- MedMen Cannabis Dispensaries and Delivery Service
- MedMen to Present at the Piper Jaffray 39th Annual Consumer Marketplace Conference
- MedMen Receives Approval in New York For Lotions and Topical Sprays
- MedMen Cannabis Dispensaries and Delivery Service
- Press Releases - Premium Marijuana Dispensary Near Me
- MedMen Cannabis Dispensaries and Delivery Service
- MedMen Cannabis Dispensaries and Delivery Service
- MedMen Cannabis Dispensaries and Delivery Service
- View more press releases Close
Social media about MedMen
- MedMen on Wikipedia, Google News & Yahoo Finance
- MedMen on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mel Elias 
